Clinical Significance of the Plasma Protein Binding of Rifampicin in the Treatment of Tuberculosis Patients Roger K. VerbeeckBonifasius S. SinguDan Kibuule Commentary 22 July 2019 Pages: 1511 - 1515
Towards Personalized Antithrombotic Treatments: Focus on P2Y12 Inhibitors and Direct Oral Anticoagulants Jean TerrierYoussef DaaliJean-Luc Reny Review Article 27 June 2019 Pages: 1517 - 1532
Exposure-Toxicity Relationships of Mycophenolic Acid in Adult Kidney Transplant Patients Tony K. L. KiangMary H. H. Ensom Review Article 22 July 2019 Pages: 1533 - 1552
Clinical Pharmacodynamics, Pharmacokinetics, and Drug Interaction Profile of Doravirine Alison BoyleCatherine E. MossSaye Khoo Review Article 07 August 2019 Pages: 1553 - 1565
Factors Contributing to Fentanyl Pharmacokinetic Variability Among Diagnostically Diverse Critically Ill Children Fanuel T. HagosChristopher M. HorvatPhilip E. Empey Original Research Article 06 June 2019 Pages: 1567 - 1576
A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Model of Dabigatran Etexilate, Dabigatran and Dabigatran Glucuronide in Healthy Adults and Renally Impaired Patients Daniel MojHugo MaasThorsten Lehr Original Research Article 18 May 2019 Pages: 1577 - 1593
Physiologically Based Pharmacokinetic Models for Prediction of Complex CYP2C8 and OATP1B1 (SLCO1B1) Drug–Drug–Gene Interactions: A Modeling Network of Gemfibrozil, Repaglinide, Pioglitazone, Rifampicin, Clarithromycin and Itraconazole Denise TürkNina HankeThorsten Lehr Original Research Article Open access 25 May 2019 Pages: 1595 - 1607
Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome Rick AdmiraalCornelia M. Jol-van der ZijdeRobbert G. M. Bredius Original Research Article Open access 27 May 2019 Pages: 1609 - 1620
Bayesian Population Model of the Pharmacokinetics of Venetoclax in Combination with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Results from the Phase III MURANO Study Rong DengLeonid GibianskyDale Miles Original Research Article 18 June 2019 Pages: 1621 - 1634